Skip to main content

Table 1 Overview of the inclusion and exclusion criteria of PROVALID, GCKD, and DIACORE

From: A prediction model for the decline in renal function in people with type 2 diabetes mellitus: study protocol

Study cohort Study setting
Inclusion Exclusion
PROVALID ▪ Aged 18–75 years
▪ Incident or prevalent DM2 with/without CKD
• Active malignancy requiring chemotherapy
GCKD ▪ Aged 18–74 years
▪ Caucasian ethnicity
▪ eGFR: 30–60 mL/min/1.73m2with or without urinary albumin excretion
▪ eGFR > 60 mL/min/1.73m2
- Albumin excretion of > 300mg/g creatinine
- Proteinuria > 500mg/day
▪ Active malignancy in the 24 months prior to inclusion
▪ Renal or other transplantations
▪ NYHA IV heart failure
DIACORE ▪ Aged ≥ 18 years
▪ Caucasian ethnicity
▪ Prevalent DM2
▪ On chronic renal replacement therapy
▪ Active malignancy
▪ Pregnancy
▪ Further diseases and infections